Urology

Recent years have seen the international standard of care for mHSPC evolve to include androgen-deprivation therapy combined with docetaxel.

A recent study evaluated PCR against conventional culture and sensitivity in diagnosing and managing complicated UTIs.

Clinical studies have demonstrated the durability of prostatic artery embolisation’s benefits over time.

A recent randomised trial evaluated the efficacy and safety of combination therapy in women with overactive bladder.

At 6 weeks, 65% of men achieve azoospermia, while 70–73% reach this milestone between weeks 10–16.

In women with recurrent UTIs, increasing water intake by 1500 mL daily reduced the number and frequency of infections.

Evidence from multiple studies and randomised controlled trials suggests that robot-assisted radical cystectomy delivers improved perioperative outcomes.

Real-world data underline that only a minority of patients complete the recommended 4–6 chemotherapy cycles.